Your browser doesn't support javascript.
loading
Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance?
Daza, Jorge; Ahmad, Ali; Shabir, Usma; Jing, Zhe; Shiekh, Mohsin; Kauffman, Eric; Guru, Khurshid A; Hussein, Ahmed A.
Affiliation
  • Daza J; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
  • Ahmad A; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
  • Shabir U; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
  • Jing Z; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
  • Shiekh M; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
  • Kauffman E; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
  • Guru KA; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
  • Hussein AA; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY. Electronic address: ahmed.aly@roswellpark.org.
Urol Oncol ; 41(10): 429.e1-429.e7, 2023 10.
Article in En | MEDLINE | ID: mdl-37423815
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Hypogonadism Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Hypogonadism Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2023 Document type: Article